Ibucon Plus Suspension is a combination analgesic and antipyretic formulation containing Ibuprofen 100 mg and Paracetamol 162.5 mg per 5 ml. It is indicated for the symptomatic relief of mild to moderate pain and fever associated with conditions such as headache, dental pain, musculoskeletal pain, and febrile illnesses. Ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID), exerts its effect by inhibiting cyclooxygenase enzymes, thereby reducing the synthesis of prostaglandins involved in inflammation and pain. Paracetamol acts centrally to elevate the pain threshold and reduce fever through its antipyretic properties. The combination provides enhanced analgesic efficacy compared to either agent alone, allowing for lower doses and potentially reducing adverse effects. Ibucon Plus Suspension is suitable for pediatric use, with dosage adjusted according to age and weight. It should be administered with caution in patients with a history of hypersensitivity to NSAIDs or paracetamol, hepatic or renal impairment, and gastrointestinal disorders. Common adverse effects may include gastrointestinal discomfort, allergic reactions, and, rarely, hepatotoxicity with overdose. Use under medical supervision is recommended to ensure appropriate dosing and to monitor for potential interactions with other medications.